Recent studies suggest that overexpression of EGFR results in poor prognosis in oral cancer and its activation is associated with malignant phenotype, inhibition of apoptosis and increased metastatic potential [1]. This evidence concerns the gene EGFR and lip and oral cavity carcinoma.